1. Home
  2. FGEN vs ABLV Comparison

FGEN vs ABLV Comparison

Compare FGEN & ABLV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • FGEN
  • ABLV
  • Stock Information
  • Founded
  • FGEN 1993
  • ABLV 2015
  • Country
  • FGEN United States
  • ABLV China
  • Employees
  • FGEN N/A
  • ABLV N/A
  • Industry
  • FGEN Biotechnology: Pharmaceutical Preparations
  • ABLV
  • Sector
  • FGEN Health Care
  • ABLV
  • Exchange
  • FGEN Nasdaq
  • ABLV Nasdaq
  • Market Cap
  • FGEN 45.1M
  • ABLV 41.5M
  • IPO Year
  • FGEN 2014
  • ABLV N/A
  • Fundamental
  • Price
  • FGEN $8.66
  • ABLV $0.70
  • Analyst Decision
  • FGEN Strong Buy
  • ABLV
  • Analyst Count
  • FGEN 2
  • ABLV 0
  • Target Price
  • FGEN $146.50
  • ABLV N/A
  • AVG Volume (30 Days)
  • FGEN 31.2K
  • ABLV 15.6K
  • Earning Date
  • FGEN 11-10-2025
  • ABLV 12-19-2025
  • Dividend Yield
  • FGEN N/A
  • ABLV N/A
  • EPS Growth
  • FGEN N/A
  • ABLV N/A
  • EPS
  • FGEN 53.38
  • ABLV 0.05
  • Revenue
  • FGEN $8,298,000.00
  • ABLV $114,319,869.00
  • Revenue This Year
  • FGEN N/A
  • ABLV N/A
  • Revenue Next Year
  • FGEN N/A
  • ABLV N/A
  • P/E Ratio
  • FGEN $0.16
  • ABLV $13.76
  • Revenue Growth
  • FGEN N/A
  • ABLV N/A
  • 52 Week Low
  • FGEN $4.85
  • ABLV $0.55
  • 52 Week High
  • FGEN $21.94
  • ABLV $1.77
  • Technical
  • Relative Strength Index (RSI)
  • FGEN 25.08
  • ABLV 30.74
  • Support Level
  • FGEN $8.30
  • ABLV $0.77
  • Resistance Level
  • FGEN $11.39
  • ABLV $0.85
  • Average True Range (ATR)
  • FGEN 0.51
  • ABLV 0.05
  • MACD
  • FGEN -0.26
  • ABLV -0.03
  • Stochastic Oscillator
  • FGEN 12.95
  • ABLV 0.00

About FGEN FibroGen Inc

FibroGen Inc is a biotechnology company focused on discovering, developing, and commercializing novel therapeutics to treat serious cancer biology and anemia. The company operates in one reportable segment: the development and commercialization of novel therapeutics to treat serious unmet medical needs. The company generates the vast majority of its revenue in Europe, followed by Japan. Virtually all of FibroGen's revenue to date has been generated from its collaboration agreements. FibroGen seeks partners with research, development, and marketing capabilities and other resources that strengthen the company's ability to advance product candidates. Geographically, it operates in United States, Japan, Europe and Others.

About ABLV Able View Global Inc.

Able View Global Inc operates as a brand management partner of international beauty and personal care brands in China. It provides full-service solutions covering marketing plan, branding, digital and social marketing, omni-channel sales, customer service, overseas logistics, warehouse, and fulfillment. The firm generates revenue from product sales by distributing and selling cross-border products from various brand owners to Chinese consumers.

Share on Social Networks: